>Mercado global de sistemas de soluções de vigilância de infeções, por produtos (software e serviços), tipo de infeção (infeções do local cirúrgico (SSI), infeções da corrente sanguínea (BSI), infeções do trato urinário (ITU), infeções da corrente sanguínea associadas à linha central (CLABSI), cateter Infeção associada do trato urinário (CAUTI) e outros), utilizador final (hospitais, instalações de cuidados continuados, clínicas, centros de cirurgia ambulatória, institutos académicos, outros), país (EUA, Canadá, México, Alemanha, Itália, Reino Unido, França, Espanha , Holanda, Bélgica, Suíça, Turquia, Rússia, Resto da Europa, Japão, China, Índia, Coreia do Sul, Austrália, Singapura, Malásia, Tailândia, Indonésia, Filipinas , Resto da Ásia-Pacífico, Brasil, Argentina, Resto da América do Sul , África do Sul, Arábia Saudita, Emirados Árabes Unidos, Egito, Israel, Resto do Médio Oriente e África) Tendências e previsões da indústria para 2028
Análise de mercado e insights: Mercado global de sistemas de soluções de vigilância de infeções
O mercado de sistemas de soluções de vigilância de infeções deverá testemunhar um crescimento do mercado a uma taxa de 13,3% no período de previsão de 2021 a 2028. O relatório Data Bridge Market Research sobre o mercado de sistemas de soluções de vigilância de infeções fornece análises e insights sobre os vários fatores que devem ser predominantes ao longo do período de previsão, ao mesmo tempo que fornece os seus impactos no crescimento do mercado. O aumento da prevalência de infeções associadas à saúde (IRAS) está a aumentar o crescimento do mercado de sistemas de soluções de vigilância de infeções.
Os sistemas de vigilância de infeções referem-se ao tipo de sistemas utilizados para monitorizar e gerir continuamente os dados de infeções associadas aos cuidados de saúde (IRAS) para avaliação de saúde pública. Diz-se que a deteção precoce da doença garante a execução adequada das medidas preventivas.
O aumento da resistência dos micróbios aos antibióticos e a elevada adoção da automatização em ambientes de cuidados de saúde atuam como os principais fatores que impulsionam o crescimento do mercado de sistemas de soluções de vigilância de infeções. O aumento da incidência de infeções associadas a hospitais em ambiente clínico, incluindo infeção do trato urinário, entre outras infeções do local cirúrgico e falta de saneamento, acelera o crescimento do mercado de sistemas de soluções de vigilância de infeções. O aumento da tendência para a automedicação, o aumento da capacidade dos sistemas informáticos para realizar processamento analítico e a não adesão aos medicamentos prescritos influenciam ainda mais o mercado dos sistemas de soluções de vigilância de infeções. Além disso, as iniciativas governamentais sob a forma de políticas, o aumento das despesas com a saúde, o aumento do número de cirurgias e as actividades de investigação e desenvolvimento afectam positivamente o mercado dos sistemas de soluções de vigilância de infecções. Além disso, a integração de software baseado na nuvem e economias emergentes amplia as oportunidades lucrativas para os players do mercado de sistemas de soluções de vigilância de infeções no período de previsão de 2021 a 2028.
Por outro lado, o elevado custo associado ao software, a relutância dos profissionais médicos em adotar ferramentas de saúde avançadas e a falta de profissionais de TI qualificados para operar atuam como os fatores que se espera que obstruam o crescimento do mercado de sistemas de soluções de vigilância de infecções. O aumento da procura de soluções baseadas na web e de plataformas móveis e a preferência dos consumidores pela automatização em instalações de saúde deverão desafiar o mercado de sistemas de soluções de vigilância de infeções no período de previsão de 2021-2028.
Este relatório de mercado de sistemas de soluções de vigilância de infeções fornece detalhes de novos desenvolvimentos recentes, regulamentos comerciais, análise de importação e exportação, análise de produção, otimização da cadeia de valor, quota de mercado, impacto dos participantes do mercado nacionais e localizados , analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, análise estratégica do crescimento do mercado, tamanho do mercado, crescimento do mercado da categoria, nichos de aplicação e domínio, aprovações de produtos, lançamentos de produtos, expansões geográficas , inovações tecnológicas no mercado. Para mais informações sobre o mercado de sistemas de soluções de vigilância de infeções, contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a tomar uma decisão de mercado informada para alcançar o crescimento do mercado.
Âmbito do mercado de sistemas de soluções de vigilância de infeções e dimensão do mercado
O mercado dos sistemas de soluções de vigilância de infeções está segmentado com base nos produtos, tipo de infeção e utilizador final. O crescimento entre estes segmentos irá ajudá-lo a analisar os escassos segmentos de crescimento nas indústrias e a fornecer aos utilizadores uma valiosa visão geral do mercado e do mercado.
- Com base em produtos, o mercado de sistemas de soluções de vigilância de infeções está segmentado em software e serviços.
- Com base no tipo de infeção, o mercado dos sistemas de soluções de vigilância de infeções está segmentado em infeções do local cirúrgico (SSI), infeções da corrente sanguínea (BSI), infeções do trato urinário (ITU), infeções da corrente sanguínea associadas ao cateter central (CLABSI), urina associada a cateter infeção do trato (CAUTI) e outros.
- Com base no utilizador final, o mercado de sistemas de soluções de vigilância de infeções está segmentado em hospitais , instalações de cuidados continuados, clínicas, centros de cirurgia ambulatória , institutos académicos e outros.
Análise global do mercado de sistemas de soluções de vigilância de infeções a nível do país
O mercado de sistemas de soluções de vigilância de infeções é analisado e são fornecidos insights e tendências do tamanho do mercado por país, produtos, tipo de infeção e utilizador final, como mencionado acima.
Os países abrangidos pelo relatório global do mercado de sistemas de soluções de vigilância de infeções são os EUA, Canadá e México na América do Norte, Alemanha, França, Reino Unido, Países Baixos, Suíça, Bélgica, Rússia, Itália, Espanha, Turquia, Resto da Europa na Europa, China , Japão, Índia, Coreia do Sul, Singapura, Malásia, Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia-Pacífico (APAC) na Ásia-Pacífico (APAC), Arábia Saudita, Emirados Árabes Unidos, África do Sul, Egito, Israel, Resto do Médio Oriente e África (MEA) como parte do Médio Oriente e África (MEA), Brasil, Argentina e Resto da América do Sul como parte da América do Sul.
A América do Norte domina o mercado dos sistemas de soluções de vigilância de infeções devido à iniciativa governamental e ao aumento da incidência de IACS nos EUA e no Canadá. Espera-se que a Ásia-Pacífico testemunhe um crescimento significativo durante o período de previsão de 2021 a 2028 devido à melhoria das infraestruturas de saúde e ao aumento do turismo médico na região.
A secção do país do relatório de mercado Sistemas de soluções de vigilância de infeções também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado nacional que impactam as tendências atuais e futuras do mercado. Pontos de dados como volumes de consumo, localizações e volumes de produção, análise de importação e exportação, análise de tendências de preços, custo das matérias-primas, análise da cadeia de valor a jusante e a montante são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias
O mercado de sistemas de soluções de vigilância de infeções também fornece análises de mercado detalhadas para o crescimento de cada país em termos de despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado de sistemas de soluções de vigilância de infeções, impacto da tecnologia utilizando curvas de linha de vida e alterações na regulamentação de saúde cenários e o seu impacto no mercado de sistemas de soluções de vigilância de infeções. Os dados estão disponíveis para o período histórico 2011-2019.
Análise da quota de mercado dos sistemas de soluções de vigilância de infeções e cenário competitivo
O panorama competitivo do mercado de sistemas de soluções de vigilância de infeções fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de sistemas de soluções de vigilância de infeções.
Os principais players abordados no relatório de mercado de sistemas de soluções de vigilância de infeções são a BD, Cerner Corporation, Illumina, Inc., RL Solutions, GOJO Industries, Inc., SC Johnson & Son, Inc., Baxter, Wolters Kluwer, Vigilanz Corporation, IBM Corporation , HyGreen Inc., Premier, Atlas MD, Deb Group Ltd entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul separadamente. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR MARKET CHALLENGE MATRIX
2.9 DBMR VENDOR SHARE ANALYSIS
2.1 MULTIVARIATE MODELING
2.11 PRODUCTS LIFELINE CURVE
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS)
3.1.2 INCREASING HEALTHCARE EXPENDITURE
3.1.3 GOVERNMENT POLICIES FOR PREVENTING HEALTH-ACQUIRED INFECTIONS (HAIS)
3.2 RESTRAINTS
3.2.1 HIGH COST OF SOFTWARE
3.2.2 DEARTH OF SKILLED IT PROFESSIONALS IN THE HEALTHCARE INDUSTRY
3.3 OPPORTUNITIES
3.3.1 CLOUD-BASED SOFTWARE OFFERS SIGNIFICANT GROWTH OPPORTUNITIES
3.3.2 HIGH GROWTH IN DEVELOPING COUNTRIES ACROSS ASIA-PACIFIC AND LATIN AMERICA
3.4 CHALLENGE
3.4.1 DATA SECURITY RISK
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS
6.1 OVERVIEW
6.2 SOFTWARE
6.2.1 WEB BASED
6.2.2 ON-PREMISE
6.3 SERVICES
6.3.1 TRAINING & CONSULTING SERVICES
6.3.2 IMPLEMENTATION SERVICES
6.3.3 PRODUCT SUPPORT & MAINTENANCE SERVICES
7 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE
7.1 OVERVIEW
7.2 SURGICAL SITE INFECTIONS (SSI)
7.3 URINARY TRACT INFECTIONS (UTI)
7.4 BLOOD STREAM INFECTIONS (BSI)
7.5 CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)
7.6 CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI)
7.7 OTHERS
8 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.2.1 LARGE HOSPITALS
8.2.2 MEDIUM-SIZED HOSPITALS
8.2.3 SMALL HOSPITALS
8.3 CLINICS
8.4 AMBULATORY SURGICAL CENTERS
8.5 LONG TERM CARE FACILITIES
8.5.1 NURSING HOMES
8.5.2 HOMECARE AGENCIES & SERVICES
8.5.3 ASSISTED LIVING FACILITIES
8.6 ACADEMIC INSTITUTES
8.7 OTHERS
9 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 NETHERLANDS
9.3.7 SWITZERLAND
9.3.8 BELGIUM
9.3.9 RUSSIA
9.3.10 TURKEY
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 SOUTH KOREA
9.4.4 INDIA
9.4.5 AUSTRALIA
9.4.6 SINGAPORE
9.4.7 THAILAND
9.4.8 MALAYSIA
9.4.9 INDONESIA
9.4.10 PHILIPPINES
9.4.11 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 REST OF SOUTH AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 SOUTH AFRICA
9.6.2 REST OF MIDDLE EAST & AFRICA
10 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
11.1 DATA BRIDGE MARKET RESEARCH ANALYSIS
12 COMPANY PROFILES
12.1 WOLTERS KLUWER
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 BD
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 ILLUMINA, INC.
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 CERNER CORPORATION
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BAXTER
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 GOJO INDUSTRIES, INC.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 IBM CORPORATION
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 RL SOLUTIONS
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 S. C. JOHNSON & SON, INC.
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENT
12.1 VIGILANZ CORPORATION
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
13 CONCLUSION
14 QUESTIONNAIRE
15 RELATED REPORTS
Lista de Tabela
TABLE 1 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 2 GLOBAL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 3 GLOBAL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 4 GLOBAL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 GLOBAL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 7 GLOBAL SURGICAL SITE INFECTIONS (SSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET,BY REGION, 2017-2026 (USD MILLION)
TABLE 8 GLOBAL URINARY TRACT INFECTIONS (UTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 GLOBAL BLOOD STREAM INFECTIONS (BSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 10 GLOBAL CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 GLOBAL CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 12 GLOBAL OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 14 GLOBAL HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 GLOBAL HOSPITAL IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 16 GLOBAL CLINICS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 GLOBAL AMBULATORY SURGICAL CENTERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 18 GLOBAL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 GLOBAL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 20 GLOBAL ACADEMIC INSTITUTES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 GLOBAL OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 24 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 25 NORTH AMERICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 26 NORTH AMERICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 27 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 28 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 29 NORTH AMERICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 30 NORTH AMERICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 31 U.S. SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 32 U.S. SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 33 U.S. SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 34 U.S. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 35 U.S. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 36 U.S. HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 37 U.S. LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 38 CANADA SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 39 CANADA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 40 CANADA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 41 CANADA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 42 CANADA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 43 CANADA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 44 CANADA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 45 MEXICO SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 46 MEXICO SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 47 MEXICO SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 48 MEXICO INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 49 MEXICO INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 50 MEXICO HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 51 MEXICO LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 52 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 53 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 54 EUROPE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 55 EUROPE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 56 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 57 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 58 EUROPE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 59 EUROPE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 60 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 61 GERMANY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 62 GERMANY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 63 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 64 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 65 GERMANY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 66 GERMANY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 67 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 68 FRANCE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 69 FRANCE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 70 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 71 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 72 FRANCE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 73 FRANCE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 74 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 75 U.K. SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 76 U.K. SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 77 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 78 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 79 U.K. HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 80 U.K. LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 81 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 82 ITALY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 83 ITALY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 84 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 85 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 86 ITALY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 87 ITALY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 88 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 89 SPAIN SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 90 SPAIN SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 91 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 92 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 93 SPAIN HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 94 SPAIN LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 95 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 96 NETHERLANDS SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 97 NETHERLANDS SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 98 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 99 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 100 NETHERLANDS HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 101 NETHERLANDS LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 102 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 103 SWITZERLAND SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 104 SWITZERLAND SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 105 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 106 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 107 SWITZERLAND HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 108 SWITZERLAND LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 109 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 110 BELGIUM SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 111 BELGIUM SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 112 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 113 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 114 BELGIUM HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 115 BELGIUM LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 116 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 117 RUSSIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 118 RUSSIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 119 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 120 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 121 RUSSIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 122 RUSSIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 123 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 124 TURKEY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 125 TURKEY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 126 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 127 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 128 TURKEY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 129 TURKEY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 130 REST OF EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 131 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 132 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 133 ASIA-PACIFIC SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 134 ASIA-PACIFIC SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 135 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 136 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 137 ASIA-PACIFIC HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 138 ASIA-PACIFIC LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 139 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 140 CHINA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 141 CHINA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 142 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 143 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 144 CHINA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 145 CHINA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 146 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 147 JAPAN SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 148 JAPAN SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 149 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 150 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 151 JAPAN HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 152 JAPAN LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 153 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 154 SOUTH KOREA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 155 SOUTH KOREA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 156 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 157 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 158 SOUTH KOREA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 159 SOUTH KOREA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 160 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 161 INDIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 162 INDIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 163 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 164 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 165 INDIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 166 INDIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 167 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 168 AUSTRALIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 169 AUSTRALIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 170 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 171 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 172 AUSTRALIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 173 AUSTRALIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 174 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 175 SINGAPORE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 176 SINGAPORE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 177 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 178 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 179 SINGAPORE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 180 SINGAPORE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 181 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 182 THAILAND SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 183 THAILAND SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 184 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 185 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 186 THAILAND HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 187 THAILAND LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 188 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 189 MALAYSIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 190 MALAYSIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 191 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 192 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 193 MALAYSIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 194 MALAYSIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 195 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 196 INDONESIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 197 INDONESIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 198 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 199 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 200 INDONESIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 201 INDONESIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 202 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 203 PHILIPPINES SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 204 PHILIPPINES SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 205 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 206 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 207 PHILIPPINES HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 208 PHILIPPINES LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 209 REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 210 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 211 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 212 SOUTH AMERICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 213 SOUTH AMERICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 214 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 215 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 216 SOUTH AMERICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 217 SOUTH AMERICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 218 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 219 BRAZIL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 220 BRAZIL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 221 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 222 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 223 BRAZIL HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 224 BRAZIL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 225 REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 226 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 227 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 228 MIDDLE EAST AND AFRICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 229 MIDDLE EAST AND AFRICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 230 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 231 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 232 MIDDLE EAST AND AFRICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 233 MIDDLE EAST AND AFRICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 234 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 235 SOUTH AFRICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 236 SOUTH AFRICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 237 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 238 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 239 SOUTH AFRICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 240 SOUTH AFRICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 241 REST OF MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
Lista de Figura
FIGURE 1 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION
FIGURE 2 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DATA VALIDATION MODEL
FIGURE 3 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: GLOBAL VS REGIONAL ANALYSIS
FIGURE 5 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 9 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE OF THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET
FIGURE 11 HEALTHCARE EXPENDITURE IN FEW COUNTRIES (2015 & 2016)
FIGURE 12 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION
FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 14 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS) AND INCREASING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 15 SOFTWARE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN 2019 & 2026
FIGURE 16 NORTH AMERICA IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 17 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS, 2018
FIGURE 18 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY INFECTION TYPE, 2018
FIGURE 19 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY END USER, 2018
FIGURE 20 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 21 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2018)
FIGURE 22 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2019 & 2026)
FIGURE 23 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2018 & 2026)
FIGURE 24 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 25 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 26 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 27 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 28 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 29 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 30 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 31 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 32 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 33 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 34 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 35 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 36 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 37 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 38 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 39 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 40 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 41 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 42 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 43 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 44 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 45 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 46 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 47 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 48 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 49 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 50 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
FIGURE 51 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
FIGURE 52 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
FIGURE 53 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
